In Focus: Severe heterozygous Familial Hypercholesterolemia (FH) and the potential role of antisense technology
This educational symposium, moderated by Prof. Alberico Catapano, Italy will discuss the unmet medical needs in patients with severe FH and examine the role of over-secretion of apolipoprotein (apo) B-100-containing lipoproteins in increasing the risk of coronary artery disease (CAD). The potential of a new class of agents – the antisense oligonucleotides – in the treatment of patients with severe disease who are unable to achieve treatment ...
Tovább